Table 2 Risk of encephalitis after COVID-19 vaccination, overall and stratified by scheduled dose and vaccine type

Encephalitis

 Overall

251

545

134.8

369.3

1.86

1.48

1.26 (1.08–1.47)

 Scheduled dose

  1st dose

106

545

60.2

369.3

1.76

1.48

1.19 (0.97–1.47)

  2nd dose

87

438

53.2

256.5

1.63

1.71

0.96 (0.76–1.20)

  3rd dose

58

83

21.3

28.2

2.72

2.94

0.92 (0.67–1.26)

 Vaccine type

  BNT162b2

123

279

69.2

188.0

1.78

1.48

1.20 (0.96–1.49)

  mRNA-1273

21

62

13.6

36.5

1.54

1.70

0.91 (0.54–1.52)

  ChAdOx1-S

44

110

19.7

73.1

2.23

1.50

1.49 (1.03–2.15)

  Ad26.COV2.S

0

7

0.5

3.4

-

2.07

-